1.Difference in Tumor Area as a Predictor of a Pathological Complete Response for Patients With Locally Advanced Rectal Cancer.
Ji Hyeong SONG ; Yo Han PARK ; Sang Hyuk SEO ; Anbok LEE ; Kwang Hee KIM ; Min Sung AN ; Ki Beom BAE ; Kwan Hee HONG ; Jin Won HWANG ; Ji Hyun KIM ; Hyun Seok JUNG ; Ki Jung AHN
Annals of Coloproctology 2017;33(6):219-226
PURPOSE: This study was conducted to discover the clinical factors that can predict pathologically complete remission (pCR) after neoadjuvant chemoradiotherapy (CRT), so that those factors may help in deciding on a treatment program for patients with locally advanced rectal cancer. METHODS: A total of 137 patients with locally advanced rectal cancer were retrospectively enrolled in this study, and data were collected retrospectively. The patients had undergone a total mesorectal excision after neoadjuvant CRT. Histologic response was categorized as pCR vs. non-pCR. The tumor area was defined as (tumor length) × (maximum tumor depth). The difference in tumor area was defined as pre-CRT tumor area – post-CRT tumor area. Univariate and multivariate logistic regression analyses were conducted to find the factors affecting pCR. A P-value < 0.05 was considered significant. RESULTS: Twenty-three patients (16.8%) achieved pCR. On the univariate analysis, endoscopic tumor circumferential rate <50%, low pre-CRT T & N stage, low post-CRT T & N stage, small pretreatment tumor area, and large difference in tumor area before and after neoadjuvant CRT were predictive factors of pCR. A multivariate analysis found that only the difference in tumor area before and after neoadjuvant CRT was an independent predictor of pCR (P < 0.001). CONCLUSION: The difference in tumor area, as determined using radiologic tools, before and after neoadjuvant CRT may be important predictor of pCR. This clinical factor may help surgeons to determine which patients who received neoadjuvant CRT for locally advanced rectal cancer should undergo surgery.
Chemoradiotherapy
;
Humans
;
Logistic Models
;
Multivariate Analysis
;
Polymerase Chain Reaction
;
Rectal Neoplasms*
;
Retrospective Studies
;
Surgeons
2.A Case of Subungual Verruca in All Fingers.
Hyun Yi SUH ; Hong Lim KIM ; Kyung Ho KIM ; Mi Youn PARK ; Jai Il YOUN ; Ji Young AHN
Korean Journal of Dermatology 2017;55(1):83-84
3.The Association between Suicidal Ideation, Anxiety, and Sleep Quality Among College Students in a City.
Shin Hyeong KIM ; Chul Soo PARK ; Bong Jo KIM ; Cheol Soon LEE ; Boseok CHA ; Dongyun LEE ; Ji Yeong SEO ; Jae Won CHOI ; In Young AHN ; So Jin LEE
Sleep Medicine and Psychophysiology 2017;24(1):55-61
OBJECTIVES: Suicide is one of the leading causes of death among young adults. We investigated whether anxiety level and sleep quality were related to suicide ideation among university students. METHODS: Questionnaires were distributed to 1094 students at a local college. The scale for suicide Ideation, the Hospital Anxiety-Depression scale, the Pittsburgh Sleep Quality Index, and Morningness-eveningness questionnaires were used. Multiple linear regression analysis was conducted to examine the relationship between these variables and suicide ideation. RESULTS: Among the 292 students who answered the suicide ideation questionnaire, 31 students had a high suicide ideation score and 261 patients had a low suicide ideation score. Demographic variables that showed significant differences between the two groups were gender, exercise, chronotype, sleep quality, depression and anxiety. The results of multiple linear regression analysis showed that suicidal ideation increased as the level of sleep quality decreased. There was no significant relationship between depression and suicidal ideation. Another multiple linear regression analysis was performed to evaluate the relationship between sleep quality sleep related factors. This suggested the quality of sleep decreased as weekend oversleep increased. CONCLUSION: The results of this study showed that when anxiety was higher and the quality of sleep was lower, the more suicide ideation increased. Therefore, improving sleep quality and reducing anxiety are important strategies for reducing suicidal ideation.
Anxiety*
;
Cause of Death
;
Depression
;
Humans
;
Linear Models
;
Suicidal Ideation*
;
Suicide
;
Young Adult
4.Prediction of pregnancy complication occurrence using fetal cardiac output assessments made by ultrasonography at 20 to 24 weeks of gestation.
Ji Yeon LEE ; Young Li KIM ; Ji Eun JEONG ; Jun Woo AHN
Obstetrics & Gynecology Science 2017;60(4):336-342
OBJECTIVE: To evaluate the importance of assessment of fetal cardiac output (CO) for the prediction of complications of pregnancy. METHODS: We evaluated 65 fetuses and all of them had a fetal cardiac scan at 20 to 24 weeks of pregnancy. To measure CO, diameters (d) of the left right ventricle outflow tract were measured just above the valves. Each left CO (LCO) and right CO (RCO) was derived using the following equation: CO = velocity time integral ×π× d²/4 × heart rate. Pregnancy complications included gestational hypertensive disorders, fetal growth restriction (FGR) and preterm birth (PTB) caused from preterm labor or preterm premature rupture of membrane (PPROM). RESULTS: There were 23 cases with one more pregnancy complication (FGR, 9; gestational hypertensive disorders, 8; PTB caused from PTB or PPROM, 12). The LCO was lower in complication group than in normal group (88±53 vs. 117±48 mL/min, P=0.028). The RCO to the LCO ratio (RCO/LCO) was higher in complication group (2.43±1.69 vs. 1.48±0.81, P=0.001). Regression analysis demonstrated that RCO/LCO was a significant predictor of pregnancy complication; Odds ratio was 7.76 (95% CI, 1.15 to 52.21; P=0.029). The area under the receiver-operating characteristic curve for prediction of pregnancy complications from LCO was 0.71. The diagnostic cut-off value of LCO was 80 mL/min. The area under the receiver-operating characteristic curve from RCO/LCO was 0.68 and cut-off value was 1.41. CONCLUSION: This study demonstrated that pregnancy complications can be suspected based on fetal CO assessments at a GA of 20 to 24 weeks.
Cardiac Output*
;
Echocardiography
;
Female
;
Fetal Development
;
Fetal Growth Retardation
;
Fetus
;
Heart Rate
;
Heart Ventricles
;
Membranes
;
Obstetric Labor, Premature
;
Odds Ratio
;
Pre-Eclampsia
;
Pregnancy Complications*
;
Pregnancy*
;
Premature Birth
;
Rupture
;
Ultrasonography*
5.Pre-treated Populus tomentiglandulosa extract inhibits neuronal loss and alleviates gliosis in the gerbil hippocampal CA1 area induced by transient global cerebral ischemia.
Joon Ha PARK ; Tae Kyeong LEE ; Ji Hyeon AHN ; Bich Na SHIN ; Jeong Hwi CHO ; In Hye KIM ; Jae Chul LEE ; Jong Dai KIM ; Young Joo LEE ; Il Jun KANG ; Seongkweon HONG ; Yang Hee KIM ; Yong Hwan JEON ; Yun Lyul LEE ; Moo Ho WON
Anatomy & Cell Biology 2017;50(4):284-292
The genus Populus (poplar) belonging to the Salicaceae family has been used in traditional medicine, and its several species show various pharmacological properties including antioxidant and anti-inflammatory effects. No study regarding protective effects of Populus species against cerebral ischemia has been reported. Therefore, in the present study, we examined neuroprotective effects of ethanol extract from Populus tomentiglandulosa (Korea poplar) in the hippocampal cornu ammonis (CA1) area of gerbils subjected to 5 minutes of transient global cerebral ischemia. Pretreatment with 200 mg/kg of P. tomentiglandulosa extract effectively protected CA1 pyramidal neurons from transient global cerebral ischemia. In addition, glial fibrillary acidic protein immunoreactive astrocytes and ionized calcium binding adapter molecule 1 immunoreactive microglia were significantly diminished in the ischemic CA1 area by pretreatment with 200 mg/kg of P. tomentiglandulosa extract. Briefly, our results indicate that pretreatment with P. tomentiglandulosa extract protects neurons from transient cerebral ischemic injury and diminish cerebral ischemia-induced reactive gliosis in ischemic CA1 area. Based on these results, we suggest that P. tomentiglandulosa can be used as a potential candidate for prevention of ischemic injury.
Astrocytes
;
Brain Ischemia*
;
Calcium
;
Ethanol
;
Gerbillinae*
;
Glial Fibrillary Acidic Protein
;
Gliosis*
;
Hippocampus
;
Humans
;
Medicine, Traditional
;
Microglia
;
Neurons*
;
Neuroprotective Agents
;
Populus*
;
Pyramidal Cells
;
Salicaceae
6.Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.
Kyung Nam KOH ; Ho Joon IM ; Hyery KIM ; Hyoung Jin KANG ; Kyung Duk PARK ; Hee Young SHIN ; Hyo Seop AHN ; Ji Won LEE ; Keon Hee YOO ; Ki Woong SUNG ; Hong Hoe KOO ; Young Tak LIM ; Jun Eun PARK ; Byung Kiu PARK ; Hyeon Jin PARK ; Jong Jin SEO
Journal of Korean Medical Science 2017;32(4):642-649
This multicenter, prospective trial was conducted to develop an effective and safe reinduction regimen for marrow-relapsed pediatric acute lymphoblastic leukemia (ALL) by modifying the dose of idarubicin. Between 2006 and 2009, the trial accrued 44 patients, 1 to 21 years old with first marrow-relapsed ALL. The reinduction regimen comprised prednisolone, vincristine, L-asparaginase, and idarubicin (10 mg/m²/week). The idarubicin dose was adjusted according to the degree of myelosuppression. The second complete remission (CR2) rate was 72.7%, obtained by 54.2% of patients with early relapse < 24 months after initial diagnosis and 95.0% of those with late relapse (P = 0.002). Five patients entered remission with extended treatment, resulting in a final CR2 rate of 84.1%. The CR2 rate was not significantly different according to the idarubicin dose. The induction death rate was 2.3% (1/44). The 5-year event-free and overall survival rates were 22.2% ± 6.4% and 27.3% ± 6.7% for all patients, 4.2% ± 4.1% and 8.3% ± 5.6% for early relapsers, and 43.8% ± 11.4% and 50.0% ± 11.2% for late relapsers, respectively. Early relapse and slow response to reinduction chemotherapy were predictors of poor outcomes. In conclusion, a modified dose of idarubicin was effectively incorporated into the reinduction regimen for late marrow-relapsed ALL with a low toxic death rate. However, the CR2 rate for early relapsers was suboptimal, and the second remission was not durable in most patients.
7.MERS-CoV Infection in a Pregnant Woman in Korea.
Soo Young JEONG ; Se In SUNG ; Ji Hee SUNG ; So Yoon AHN ; Eun Suk KANG ; Yun Sil CHANG ; Won Soon PARK ; Jong Hwa KIM
Journal of Korean Medical Science 2017;32(10):1717-1720
Middle East respiratory syndrome (MERS) is a lethal respiratory disease — caused by MERS-coronavirus (MERS-CoV) which was first identified in 2012. Especially, pregnant women can be expected as highly vulnerable candidates for this viral infection. In May 2015, this virus was spread in Korea and a pregnant woman was confirmed with positive result of MERS-CoV polymerase chain reaction (PCR). Her condition was improved only with conservative treatment. After a full recovery of MERS, the patient manifested abrupt vaginal bleeding with rupture of membrane. Under an impression of placenta abruption, an emergent cesarean section was performed. Our team performed many laboratory tests related to MERS-CoV and all results were negative. We report the first case of MERS-CoV infection during pregnancy occurred outside of the Middle East. Also, this case showed relatively benign maternal course which resulted in full recovery with subsequent healthy full-term delivery without MERS-CoV transmission.
Cesarean Section
;
Coronavirus
;
Coronavirus Infections
;
Female
;
Humans
;
Korea*
;
Membranes
;
Middle East
;
Middle East Respiratory Syndrome Coronavirus*
;
Placenta
;
Polymerase Chain Reaction
;
Pregnancy
;
Pregnant Women*
;
Rupture
;
Uterine Hemorrhage
8.Histopathological Findings of Intracranial Thrombi in Nonbacterial Thrombotic Endocarditis.
Kyoungsub KIM ; Jayoung KIM ; Seong Hwan AHN ; Woo Seok HA ; Yu Jin KOO ; Dong Joon KIM ; Hyo Suk NAM ; Ji Hoe HEO
Journal of Stroke 2017;19(3):367-369
No abstract available.
Endocarditis*
9.Prognostic Significance of Troponin Elevation for Long-Term Mortality after Ischemic Stroke.
Sung Ho AHN ; Ji Sung LEE ; Young Hak KIM ; Bum Joon KIM ; Yeon Jung KIM ; Dong Wha KANG ; Jong S KIM ; Sun U KWON
Journal of Stroke 2017;19(3):312-322
BACKGROUND AND PURPOSE: Troponin, a marker of myocardial injury, frequently increases and is related with poor outcome in ischemic stroke patients. However, the long-term outcome of this elevation remains uncertain. We, therefore, investigated the prognostic significance of troponin elevation for long-term mortality, and explored factors affecting troponin elevation after ischemic stroke. METHODS: We retrospectively analyzed the medical data of stroke patients who were admitted within 24 hours of symptom onset and underwent a serum cardiac troponin I test at admission during a five-year period. Information on mortality as the outcome was obtained from the National Death Certificate system. RESULTS: A total of 1,692 patients were eligible for inclusion with 33 months of median follow-up. Troponin elevation that exceeded the 99th percentile (>0.04 ng/mL) of values was detected in 166 patients (9.8%). After adjusting for baseline characteristics, troponin elevation was associated with previous ischemic heart disease and congestive heart failure, comorbid atrial fibrillation and active cancer, and increased National Institutes of Health Stroke Scale score. Patients with troponin elevation had a high risk of overall death (hazard ratio [HR] 1.83, 95% confidence interval [CI] 1.40–2.40), including stroke-related (HR 1.71, 95% CI 1.14–2.55), cardiac-related (HR 3.17, 95% CI 1.49–6.74), and cancer-related (HR 1.98, 95% CI 1.14–3.45) death than those without troponin elevation. CONCLUSIONS: Troponin elevation in the acute stage of ischemic stroke was associated with long-term mortality, mainly due to increased stroke- and cancer-related death in the first year and cardiacrelated death in the later period.
Atrial Fibrillation
;
Death Certificates
;
Follow-Up Studies
;
Heart Failure
;
Humans
;
Mortality*
;
Myocardial Ischemia
;
National Institutes of Health (U.S.)
;
Prognosis
;
Retrospective Studies
;
Stroke*
;
Troponin I
;
Troponin*
10.Comparison of Safety of Sedatives Versus General Anesthesia in Laser Therapy for Retinopathy of Prematurity.
Yo Han HO ; Jin Hwa CHOI ; Ji Sook KIM ; Se In SUNG ; So Yoon AHN ; Sang Jin KIM ; Yun Sil CHANG ; Won Soon PARK
Neonatal Medicine 2017;24(2):71-76
PURPOSE: Laser therapy for retinopathy of prematurity (ROP) is commonly performed under general anesthesia (GA). However, the use of GA for laser therapy in neonates who have already undergone invasive ventilation may lead to postoperative complications such as severe apnea or the development of ventilator dependency. This study aimed to examine the safety of administering only sedatives instead of GA in extremely low birth weight (ELBW) infants, who are the usual recipients of laser therapy for ROP. METHODS: Among ELBW infants who were admitted to the neonatal intensive care unit (NICU) at Samsung Medical Center between January and December 2012, we studied 30 patients treated with laser therapy for ROP. RESULTS: The mean gestational age of the patients was 24.6±1.9 weeks, with a mean birth weight of 646±140 g. The mean age and weight of patients at the time of laser therapy for ROP was 36.3±2.3 weeks and 1,470±423 g. In terms of sedatives, 14 patients (46.7%) were administered chloral hydrate alone, 14 (46.7%) were administered a combination of chloral hydrate and midazolam, one was administered midazolam alone, and one received fentanyl. Prior to laser therapy, 16 patients (53.5%) had established self-respiration, 13 (43.3%) relied on non-invasive ventilation and one patient relied on invasive mechanical ventilation. Following laser therapy, two patients who initially had exhibited self-respiration required respiratory assistance via non-invasive positive pressure ventilation and no patient required intratracheal intubation. CONCLUSIONS: We conclude that the use of sedatives may be safe for ELBW infants who undergo laser therapy for ROP.
Anesthesia, General*
;
Apnea
;
Birth Weight
;
Chloral Hydrate
;
Fentanyl
;
Gestational Age
;
Humans
;
Hypnotics and Sedatives*
;
Infant
;
Infant, Low Birth Weight
;
Infant, Newborn
;
Intensive Care, Neonatal
;
Intubation, Intratracheal
;
Laser Therapy*
;
Midazolam
;
Noninvasive Ventilation
;
Positive-Pressure Respiration
;
Postoperative Complications
;
Respiration, Artificial
;
Retinopathy of Prematurity*
;
Ventilation
;
Ventilators, Mechanical

Result Analysis
Print
Save
E-mail